Gentiva Reports Fourth Quarter and Fiscal 20...(trative expenses (11...)

Date:2/18/2009

trative expenses (119,093) (113,247) (490,451) (444,042) Gain on sale of business, net 61 - 107,933 - Interest expense (3,501) (6,636) (19,377) (27,285) Interest income 1,012 768 2,290 3,204 ----- --- ----- ----- Income before income taxes 22,031 14,127 182,930 55,582 Income tax expense 9,165 5,281 29,445 22,754 ----- ----- ------ ------ Income before equity in net loss of affiliate 12,866 8,846 153,485 32,828 Equity in net loss of affiliate (55) - (35) - --- --- --- --- Net income $12,811 $8,846 $153,450 $32,828 ======= ====== ======== ======= Earnings per Share ------------------ Net income: Basic $0.44 $0.32 $5.37 $1.18 ===== ===== ===== ===== Diluted $0.43 $0.31 $5.21 $1.15 ===== ===== ===== ===== Average shares outstanding: Basic 28,845 28,006 28,578 27,798 ====== ====== ====== ====== Diluted 29,861 28,781 29,439 28,599 ====== ====== ====== ====== Condensed Balance Sheets (A) ----------------- ASSETS Dec 28, 2008 Dec 30, 2007
'/>"/>

SOURCE Gentiva Health Services, Inc. Copyright©2009 PR Newswire. All rights reserved

1 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Related biology technology :

1. Gentiva Reports Strong Second Quarter led by Home Health Segment
2. Water Street Health Care Partners Completes Agreement With Gentiva Health Services to Acquire Majority Ownership of CareCentrix
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. QMed, Inc. Reports July Medicare SNP Enrollments
5. Phlo Affiliate Reports Expanded Coverage to Oregon Border
6. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
7. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
8. Carrington Reports Second Quarter 2007 Results
9. Avitar Reports Third Quarter Financial Results for Fiscal 2007
10. Response Genetics Reports Second Quarter 2007 Financial Results
11. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results